Evaluation of allergenic properties and immunotoxicity of dipeptide mimetic of brain-derived neurotrophic factor GSB-106

Abstract. The study of allergenic properties and immunotoxic effects of the ready-to-use drug form of GSB-106 was carried out. The study of allergenic properties and immunotoxicity of GSB-106 was performed on male albino guinea pigs weighing 250-300 g and on male CBA, C57BL / 6, F1 hybrids (CBAxC57BL / 6) mice. When assessing immunotoxicity, GSB-106 was inject to mice per os for 14 days in doses of 2.2 mg / kg and 22 mg / kg. When studying the allergenicity, GSB-106 was injected to albino guinea pigs in doses of 1 mg / kg and 10 mg / kg according to standard regimens of immunization. The results of the study of the immunotoxicity and allergenicity of GSB-106 allow us to conclude that the injection of the ready-to-use drug form of GSB-106 in the range of studied doses does not have an immunotoxic effect and does not have allergenic properties.

1. Gudasheva TA, Logvinov IO, Antipova TA, Seredenin SB. Academy of Science Reports, 2013;451(5):577-580. (In Russ).

2. Kovalenko LP, Fedoseeva VN, Durnev AD, et al. Metodicheskie recomendaciipo otsenke aUergiziruushchih svoistv lekarstvennih sredstv. Rukovodstvo po provedeniu doklinicheskih issledovanii lekarstvennih sredstv. Ch.1. Moscow: Grif i K; 2012, 1(2), 51-63. (In Russ).

3. Metodicheskie recomendacii po otsenke immunotoksicheskogo deistviia farmakologicheskih veshchestv. Rukovodstvo po provedeniu doklinicheskih issledovanii lekarstvennih sredstv. Ch.1. Moscow: Grif i K; 2012, 1(3), 64—79. (In Russ).]

4. Haitov RM, Gushchin IS, Pinegin BV, et al. Metodicheskie recomendacii po doklinicheskomu izucheniiu immunotropnoi aktivnosti farmakologicheskih veshchestv. Rukovodstvo po provedeniu doklinicheskih issledovanii lekarstvennih sredstv. Ch.1. Moscow: Grif i K; 2012, 1(38), 626—656. (In Russ).